Parallel Bio
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
200 Dexter Ave, Watertown, Massachusetts...Website
parallel.bioRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Parallel Bio
Parallel Bio is pioneering human-first drug discovery by combining organoids and AI to create true-to-life models of human biology. The company developed the first platform that replicates the human immune system across diverse populations, predicting drug success and identifying disease targets with accuracy and speed far beyond the limits of traditional animal models. Pharmaceutical partners, including three Fortune 500 companies, are using its Clinical Trial in a Dish to test the safety and efficacy of immunotherapies. Based in Cambridge, Mass., Parallel Bio was founded in 2021 by two scientists behind the world's first scalable human immune organoid.Explore more
Parallel Bio Org Chart
VC
Associate Scientist
HA
Research Associate
SP
Associate Scientist
AJ
Research Associate
KV
Associate Scientist
JJ
Software Engineer
AG
Senior Scientist
MD
Scientist
FL
Senior Scientist
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Parallel Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Parallel Bio is spiking on competitors!
Product Launch: Get notified when Parallel Bio launches new products
Funding: Get notified immidiatlly once Parallel Bio has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Parallel Bio had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Parallel Bio
Earning: See what the market has to say on Parallel Bio recently announced quarterly report
Check if Parallel Bio has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Parallel Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Parallel Bio as Masked Content
Find 3 more new buyers
Compare Similar Companies to Parallel Bio
Compare insights from companies similar to Parallel Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Parallel Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Parallel Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Parallel Bio.
Parallel Bio financials insights
Gather financial insights about Parallel Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Angel/Seed
$4.3M
2025
Series A
$21M
Parallel Bio Tech Stack
A closer look at the technologies used by Parallel Bio
Most Recent Scoops
Hiring Plans
Parallel Bio has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Technologies mentioned include: Palantir, and React . Areas of expertise include: Palantir Foundry, Laboratory Equipment, Cloud Infrastructure, Technical Leadership, Metabolomics, Systems Architecture, and Windows Software.
Hiring Plans
Funding
Funding
Left Company
Executive Move
Parallel Bio has announced that Dwight Morrow has joined the organization as Vice President & Head of Platform. Previously, Morrow served as Vice President, Platform Innovation for Rubius Therapeutics.
Funding
Open Position
Parallel Bio News & Media
Parallel Bio Appoints Deep Tech Innovator Ari Gesher as Head of Technology
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ari Gesher, former deep tech leader at Insight M and Palantir, joins Parallel Bio as first head of technologyParallel Bio Launches Clinical Trial in a Dish to Speed Drug Discovery
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company using the immune system to cure disease, today announced the release of its Clinical Trial in a Dish for studying the efficacy and safety of new immunotherapies using human models at the earliest stages of drug discovery. Five pharmaceutical companies, including a Fortune 500 firm, have begun testing 20 drug candidates with the alternative to animal tests. Clinical Trial in a Dish creates human models using immune organoidsParallel Bio Expands Scientific Leadership and Advisors from GSK, MIT, and Stanford
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company unlocking the human body’s own power to cure disease, today announced the appointment of Dwight Morrow, a 17-year GSK veteran, as vice president and head of platform. The company also welcomed its first scientific advisors: Darrell Irvine, a professor at Massachusetts Institute of Technology and investigator at the Howard Hughes Medical Institutes, and Nima Aghaeepour, associate professor and associate vice chair of research - dParallel Bio Secures $4.3 Million Seed Round to Accelerate Drug Discovery through Human Immune System in a Dish
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company unlocking the human body’s own power to cure disease, today unveiled $4.3 million in seed funding. The investment capital has enabled it to prove the viability of its immune-system-in-a-dish platform and accelerate the pace of drug discovery and development. The seed funding was led by Refactor Capital, with other investors including Breakout Ventures; Jeff Dean, SVP of Google AI; Y Combinator; several biotech-focused funds; and
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Parallel Bio
Sign Up For FreeTo access detailed company insights
Parallel Bio is pioneering human-first drug discovery by combining organoids and AI to create true-to-life models of human biology. The company developed the first platform that replicates the human immune system across diverse populations, predicting drug success and identifying disease targets with accuracy and speed far beyond the limits of trad... Read More
